Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Systemic amyloidosis associated with chronic lymphocytic leukemia/small lymphocytic lymphoma.

Kourelis TV, Gertz M, Zent C, Lacy M, Kyle R, Kapoor P, Zeldenrust S, Buadi F, Witzig T, Hayman S, Lust J, Russell S, Lin Y, Rajkumar VS, Kumar S, Leung N, Dingli D, Dispenzieri A.

Am J Hematol. 2013 May;88(5):375-8. doi: 10.1002/ajh.23413.

2.

Simultaneous presentation of kappa-restricted chronic lymphocytic leukemia and lambda light chain AL amyloidosis.

von Keudell G, Sanchorawala V, O'Hara C, C Seldin D, Sloan JM.

Amyloid. 2014 Jun;21(2):124-7. doi: 10.3109/13506129.2013.854205.

PMID:
24471777
3.

Concurrent nephrotic syndrome and acute renal failure caused by chronic lymphocytic leukemia (CLL): a case report and literature review.

Dou X, Hu H, Ju Y, Liu Y, Kang K, Zhou S, Chen W.

Diagn Pathol. 2011 Oct 13;6:99. doi: 10.1186/1746-1596-6-99. Review.

4.

Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.

Bergesio F, Ciciani AM, Manganaro M, Palladini G, Santostefano M, Brugnano R, Di Palma AM, Gallo M, Rosati A, Tosi PL, Salvadori M; Immunopathology Group of the Italian Society of Nephrology..

Nephrol Dial Transplant. 2008 Mar;23(3):941-51.

5.

Amyloidosis associated with chronic lymphocytic leukemia.

Ikee R, Kobayashi S, Hemmi N, Suzuki S, Miura S.

Amyloid. 2005 Jun;12(2):131-4.

PMID:
16011991
6.

The spectrum of kidney pathology in B-cell chronic lymphocytic leukemia / small lymphocytic lymphoma: a 25-year multicenter experience.

Poitou-Verkinder AL, Francois A, Drieux F, Lepretre S, Legallicier B, Moulin B, Godin M, Guerrot D.

PLoS One. 2015 Mar 26;10(3):e0119156. doi: 10.1371/journal.pone.0119156.

7.

Amyloidomas of the nervous system: a monoclonal B-cell disorder with monotypic amyloid light chain lambda amyloid production.

Laeng RH, Altermatt HJ, Scheithauer BW, Zimmermann DR.

Cancer. 1998 Jan 15;82(2):362-74.

PMID:
9445195
8.

Clinical features and treatment response of light chain (AL) amyloidosis diagnosed in patients with previous diagnosis of multiple myeloma.

Madan S, Dispenzieri A, Lacy MQ, Buadi F, Hayman SR, Zeldenrust SR, Rajkumar SV, Gertz MA, Kumar SK.

Mayo Clin Proc. 2010 Mar;85(3):232-8. doi: 10.4065/mcp.2009.0547.

9.

The degrees of plasma cell clonality and marrow infiltration adversely influence the prognosis of AL amyloidosis patients.

Perfetti V, Colli Vignarelli M, Anesi E, Garini P, Quaglini S, Ascari E, Merlini G.

Haematologica. 1999 Mar;84(3):218-21.

10.

Kidney and liver involvement in monoclonal light chain disorders.

Pozzi C, Locatelli F.

Semin Nephrol. 2002 Jul;22(4):319-30. Review.

PMID:
12118397
11.

Serum levels of free light chain before and after chemotherapy in primary systemic AL amyloidosis.

Matsuda M, Yamada T, Gono T, Shimojima Y, Ishii W, Fushimi T, Sakashita K, Koike K, Ikeda S.

Intern Med. 2005 May;44(5):428-33.

12.

Systemic AL amyloidosis due to non-Hodgkin's lymphoma: an unusual clinicopathologic association.

Cohen AD, Zhou P, Xiao Q, Fleisher M, Kalakonda N, Akhurst T, Chitale DA, Moscowitz C, Dhodapkar MV, Teruya-Feldstein J, Filippa D, Comenzo RL.

Br J Haematol. 2004 Feb;124(3):309-14.

PMID:
14717777
13.

Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features.

Kumar S, Dispenzieri A, Katzmann JA, Larson DR, Colby CL, Lacy MQ, Hayman SR, Buadi FK, Leung N, Zeldenrust SR, Ramirez-Alvarado M, Clark RJ, Kyle RA, Rajkumar SV, Gertz MA.

Blood. 2010 Dec 9;116(24):5126-9. doi: 10.1182/blood-2010-06-290668.

14.

Immunoglobulin light chain amyloidosis is diagnosed late in patients with preexisting plasma cell dyscrasias.

Kourelis TV, Kumar SK, Go RS, Kapoor P, Kyle RA, Buadi FK, Gertz MA, Lacy MQ, Hayman SR, Leung N, Dingli D, Lust JA, Lin Y, Zeldenrust SR, Rajkumar SV, Dispenzieri A.

Am J Hematol. 2014 Nov;89(11):1051-4. doi: 10.1002/ajh.23827.

15.

Two distinct syndromes of lymphoma-associated AL amyloidosis: a case series and review of the literature.

Telio D, Bailey D, Chen C, Crump M, Reece D, Kukreti V.

Am J Hematol. 2010 Oct;85(10):805-8. doi: 10.1002/ajh.21814. Review.

16.

Primary systemic amyloidosis with delayed progression to multiple myeloma.

Rajkumar SV, Gertz MA, Kyle RA.

Cancer. 1998 Apr 15;82(8):1501-5.

PMID:
9554527
17.

The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: a retrospective multicentric GIMEMA experience.

Laurenti L, Tarnani M, Nichele I, Ciolli S, Cortelezzi A, Forconi F, Rossi D, Mauro FR, D'Arena G, Del Poeta G, Montanaro M, Morabito F, Musolino C, Callea V, Falchi L, Tedeschi A, Ambrosetti A, Gaidano G, Leone G, Foà R.

Am J Hematol. 2011 Dec;86(12):1007-12. doi: 10.1002/ajh.22171.

18.

Membranoproliferative glomerulonephritis and light-chain nephropathy in association with chronic lymphocytic leukemia.

Mutluay R, Aki SZ, Erten Y, Konca C, Yagci M, Barit G, Sindel S.

Clin Nephrol. 2008 Dec;70(6):527-31.

PMID:
19049712
19.

[Kidney failure in a patient with chronic B-lymphocytic leukaemia (B-CLL) with underlying cast nephropathy. The value of free immunoglobulin light chain identification for early diagnosis of this complication].

Adam Z, Stepánková S, Sirotková A, Cermáková Z, Pour L, Krejcí M, Zahradová L, Korístek Z, Lenz J, Hájek R, Vorlícek J, Mayer J.

Vnitr Lek. 2011 Feb;57(2):214-21. Czech.

PMID:
21416862
20.

Long-term follow-up of plasma cells in bone marrow and serum free light chains in primary systemic AL amyloidosis.

Yoshida T, Matsuda M, Katoh N, Tazawa K, Shimojima Y, Gono T, Ishii W, Nakazawa Y, Sakashita K, Koike K, Yamada T, Ikeda S.

Intern Med. 2008;47(20):1783-90.

Items per page

Supplemental Content

Support Center